The Validation study of Adjuvant Online using Iranian breast cancer data

Abstract

Background: Adjuvant Online! (AOL) is used extensively by oncologists in Iran to treat patients with breast cancer; however, it has never been validated for use in Iran, and its predictions might not be applicable to Iranian patients. The aim of this study was to evaluate the usefulness of this program in predicting the outcomes of Iranian patients with breast cancer.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By